As the United States braces for a bleak winter, hospital systems across the country are ramping up their efforts to develop AI systems to predict how likely their Covid-19 patients are to fall severely ill or even die. Yet most of the efforts are being developed in silos and trained on limited datasets, raising crucial questions about their reliability.
(Reuters) - AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.
Noting that the virus had sickened over 3.6 million people and killed more than 76,000 in the region over the past nine months, al-Mandhari warned “the lives of as many people — if not more — are at stake,” urging action to “prevent this tragic premonition from becoming a reality.”
More than 60% of all new infections in the past week were reported from Iran, Jordan and Morocco, he said. Cases are also up in Pakistan and Lebanon, which went under lockdown earlier this week. Jordan, Tunisia and Lebanon have reported the biggest single-day death spikes from the region.
Worst off in the region has been Iran, where infections have soared in recent months, filling up hospitals and driving up the death toll. Iran shattered its single-day death toll six times in the last two weeks, bringing the total count of fatalities past 43,400 — the highest in the Middle East. ...
The promising news that not just one but two coronavirus vaccines were more than 90 percent effective in early results has buoyed hopes that an end to the pandemic is in sight.
But even if the vaccines are authorized soon by federal regulators — the companies developing them have said they expect to apply soon — only a sliver of the American public will be able to get one by the end of the year. The two companies, Pfizer and Moderna, have estimated they will have 45 million doses, or enough to vaccinate 22.5 million Americans, by January.
WASHINGTON (AP) — U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed entirely at home and delivers results in 30 minutes.
Recent Comments